GSK And Pfizer Assemble Consumer Healthcare Leadership Team As JV Closes
GSK And Pfizer Assemble Consumer Healthcare Leadership Team As JV Closes
$131.00
GlaxoSmithKline PLC and Pfizer Inc. have closed their consumer health joint venture to create the “global leader in OTC products.” Operating under the GSK Consumer Healthcare name, the joint venture – announced in December last year – has around a 7.3% share of the global consumer health market, well ahead of the next competitor, Johnson & Johnson, at 4.1%. Under the leadership of Brian McNamara, the new company has begun to assemble a management team that combines talent from both GSK and Pfizer. Who’s on the dream team, and what’s on the horizon for this new superpower?
Author: Informa Pharma Intelligence
Publisher: HBW
- Description
Hailed by its parent companies as the “global leader in OTC products”, GSK Consumer Healthcare is the joint venture of GlaxoSmithKline PLC and Pfizer Inc. First announced in December last year, GSK Consumer Healthcare has around a 7.3% share of the global consumer health market – well ahead of the next competitor, Johnson & Johnson, at 4.1%. At the helm is Brian McNamara, who has big plans for the JV, first but he has to assemble a management team that combines all-star talent from both GSK and Pfizer. Find out who’s on the roster, and who’s replacing whom.
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
CBD Suits Challenge ‘THC-Free’ Claims After Users Fail Drug Tests; Plaintiffs... 
Sign up to the